Effects of genetic background on tumorigenesis in p53‐deficient mice
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Mice with disrupted germline p53 alleles have been engineered by us and others and have been shown to have enhanced susceptibility to spontaneous tumors of various types. We monitored a large number of p53‐deficient mice(p53+/− and p53−/−) and their wild‐type littermates(p53+/+) of two different genetic backgrounds(129/5v and mixed C57BL/6 × 129/5v) up to 2 yr of age.p53+/− and p53−/− 129/Sv mice show accelerated tumorigenesis rates compared with their p53‐deficient counterparts of mixed C57BL/6 × 129/Sv genetic background. The tumor spectra of the two strains of mice are similar except that almost half of 129/Sv p53−/− males develop malignant teratomas, whereas these tumors are rarely observed in C57BL/6 × 129/Sv mice and never in 129/Sv p53+/− males. In the study reported here, we further characterized the lymphomas that arose in the p53‐nullizygous mice and found that over three‐quarters of the lymphomas were of thymic origin and contained primarily immature(CD4+/CD8+) T‐cells, whereas the remainder originated in the spleen and peripheral lymph nodes and were of B‐cell type. The high incidence of early‐onset lymphomas in the nullizygous mice makes these animals a good lymphoma model, whereas the heterozygous mice may be a useful model for Li‐Fraumeni syndrome, a human inherited cancer predisposition.© 1995 Wiley‐Liss, Inc
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Extensive aCGH studies on human cancers using a variety of platforms have revealed widespread focal amplifications and deletions in human cancers which are now known to harbor oncogenes and tumor suppressor genes, respectively (113).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [113]
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationGerm Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542
Self-citationKemp, C. J., Donehower, L. A., Bradley, A., & Balmain, A. (1993) · Cell · doi:10.1016/0092-8674(93)90461-x · Cited by 457
Self-citationLavigueur, A., Maltby, V, Mock, D., Rossant, J., Pawson, T., & Bernstein, A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3982 · Cited by 394
Spontaneous Testicular Teratomas in an Inbred Strain of Mice
Stevens, L. C., & Little, C. C. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.11.1080 · Cited by 379
Research works printed but not linked: 1
- Stevens LC, 1979, Inbred and Genetically Defined Strains of Laboratory Animals: Mouse and Rat, 207
Cited by
Items 201–251 of 251
GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice
Friend, N., Noll, J. E., Opperman, K. S., Clark, K. C., Mrozik, K. M., Vandyke, K., Hewett, D. R., & Zannettino, A. C. W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228408 · Cited by 5
Sung, Y. H., Park, J., Choi, B., Kim, J., Cheong, C., Choi, Y. S., Yang, E. Y., Lee, M. J., Han, J., Park, S. C., et al. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.01.007 · Cited by 5
Self-citationOkamura, M., Kashida, Y., Watanabe, T., Yasuhara, K., Onodera, H., Hirose, M., Usui, T., Tamaoki, N., & Mitsumori, K. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00586-3 · Cited by 4
Tongue Carcinogenic Susceptibility of p53 Deficient Mice to Methyl-n-amylnitrosamine
Shirai, N., Tsukamoto, T., Yamamoto, M., Iidaka, T., Sakai, H., Yanai, T., Masegi, T., Donehower, L. A., & Tatematsu, M. (2002) · Journal of Toxicologic Pathology · doi:10.1293/tox.15.209 · Cited by 4
Self-citationE-cadherin loss in Cd44-positive gastric cells initiates diffuse gastric cancer in a murine model
Decourtye, L., Schulpen, E., McElroy, K., Charlton, A., der Post, R. V., Godwin, T. D., Bougen-Zhukov, N. M., Garcia‐Pelaez, J., Chen, A., Zou, D., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-336182 · Cited by 4
Targeting sphingosine kinase 1 in p53KO thymic lymphoma
Velazquez, F. N., Stith, J. L., Zhang, L., Allam, A. M., Haley, J. D., Obeid, L. M., Snider, A. J., & Hannun, Y. A. (2023) · The FASEB Journal · doi:10.1096/fj.202301417r · Cited by 3
Yun, W. B., Kim, J. E., Lee, M. L., Choi, J. Y., Park, J. J., Song, B., Kang, B. C., Nam, K. T., Lee, H., & Hwang, D. Y. (2021) · Laboratory Animal Research · doi:10.1186/s42826-021-00107-y · Cited by 3
Miller, C. R., Karpinich, N. O., Zhang, Q., Bullitt, E., Kozlov, S., & Dyke, T. V. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_7 · Cited by 4
The p53-Deficient Mouse as a Cancer Model
Venkatachalam, S., Tyner, S. D., & Donehower, L. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-100-8_14 · Cited by 3
Self-citationMartin, K. R. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh226 · Cited by 3
Tsukamoto, T., Hirata, A., & Tatematsu, M. (2005) · Journal of Toxicologic Pathology · doi:10.1293/tox.18.121 · Cited by 3
DNA repair and malignant hematopoiesis
van Veelen, L. R., Kanaar, R., & van Gent, D. C. (2004) · CRC Press eBooks · doi:10.1201/b14440-13 · Cited by 6
The role of genetically modified mouse models in predictive toxicology
Cantor, G. H. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511779053.016 · Cited by 2
Mutant p53-Driven Tumorigenesis
Terzian, T., & Lozano, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8_5 · Cited by 2
Molecular Mechanism of Gastric Carcinogenesis in Helicobacter pylori-Infected Rodent Models
Toyoda, T., Yamamoto, M., Takasu, S., Ogawa, K., Tatematsu, M., & Tsukamoto, T. (2014) · Diseases · doi:10.3390/diseases2020168 · Cited by 2
Organ‐dependent susceptibility of p53 knockout mice to 2‐amino‐3‐methylimidazo[4,5‐f]quinoline (IQ)
Hirata, A., Tsukamoto, T., Yamamoto, M., Takasu, S., Sakai, H., Ban, H., Yanai, T., Masegi, T., Donehower, L. A., & Tatematsu, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00517.x · Cited by 2
Self-citationUmesako, S., Iiga, S., Takahashi, M., Imura, K., Mori, N., Hong, D.-P., Song, C.-W., Niwa, O., & Okumoto, M. (2007) · Journal of Radiation Research · doi:10.1269/jrr.06064 · Cited by 2
Generation of a uniform thymic malignant lymphoma model with C57BL/6J p53 gene deficient mice
Liu, S., Lyu, J., Li, Q., Wu, X., Yang, Y., Huo, G., Zhu, Q., Guo, M., Shen, Y., Wang, S., et al. (2021) · Journal of Toxicologic Pathology · doi:10.1293/tox.2021-0022 · Cited by 2
Martin, K. R., Jokinen, M. P., Honeycutt, H., Quinn, A., Kari, F. W., Barrett, J. C., & French, J. E. (2004) · Toxicologic Pathology · doi:10.1080/01926230490462129 · Cited by 2
Angarola, B. L., Sharma, S. M., Katiyar, N., Kang, H. G., Nehar-Belaid, D., Park, S., Gott, R., Eryilmaz, G. N., LaBarge, M. A., Palucka, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.20.563147 · Cited by 2
Self-citationAdenoviral and Transgenic Approaches for the Conditional Deletion of Genes from Mammary Tissue
Wagner, K., Rucker, E. B., & Hennighausen, L. G. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4295-7_24 · Cited by 2
Genetically Engineered Animal Models in Toxicologic Research
Himmel, L. E., Wilson, K. L., Santagostino, S. F., & Bolon, B. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821044-4.00024-8 · Cited by 1
Lessons on p53 from Mouse Models
Jiang, D., & Attardi, L. D. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_2 · Cited by 1
Hirata, A., Tsukamoto, T., Yamamoto, M., Takasu, S., Sakai, H., Ban, H., Yanai, T., Masegi, T., Donehower, L. A., & Tatematsu, M. (2007) · Oncology Reports · doi:10.3892/or.18.4.755 · Cited by 1
Self-citationFan, H., Yu, I., Lin, Y., Wang, S., Liaw, Y., Chen, P., Yang, T., Lin, S., & Chen, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201802027r · Cited by 2
Animal Models for Tumor Suppressor Genes
Kreidberg, J. A., & Natoli, T. A. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_1 · Cited by 1
The p53 Transcription Factor as Therapeutic Target in Cancer
Asker, C., Bykov, V. J. N., Méndez‐Vidal, C., Selivanova, G., Wilhelm, M., & Wiman, K. G. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18932-6_7 · Cited by 1
Mouse Hematolymphoid Neoplasms
Rehg, J. E. (2021) · Wiley eBooks · doi:10.1002/9781119624608.ch8 · Cited by 1
Dixon, D., Nikitin, A. Y., & Mahler, J. F. (2021) · Wiley eBooks · doi:10.1002/9781119624608.ch19 · Cited by 1
Threadgill, D. W., Hunter, K. W., Zou, F., & Manly, K. F. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc015 · Cited by 1
Abschätzung des Krebsrisikos durch genetische Analyse?
Luz, A. (1997) · Strahlentherapie und Onkologie · doi:10.1007/bf03038183 · Cited by 1
Genetic Control of Susceptibility to Testicular Cancer
Lam, M.-Y. (2005) · OhioLink ETD Center (Ohio Library and Information Network)
Developing Genetically Engineered Mouse Models to Study Tumor Suppression
Xiong, S., Parker‐Thornburg, J., & Lozano, G. (2012) · Current Protocols in Mouse Biology · doi:10.1002/9780470942390.mo110159 · Cited by 2
Expression and function of the small immune adaptor protein SAP
Nagy, N. (2006) · Figshare
Uwagawa, S., Ozaki, K., Sukata, T., Kushida, M., Okuno, Y., & Fukushima, S. (2003) · Journal of Toxicologic Pathology · doi:10.1293/tox.16.147
Ayanga, B. A., Price, R., Gu, X., Lozano, G., & Evans, S. C. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20328
Mechanism of benzo(a)pyrene-induced accumulation of p53 tumour suppressor protein in mouse
Serpi, R. (2003) · Cited by 2
IN VIVO SIGNIFICANCE OF THE MDM4 AND P73 INTERACTION DURING DEVELOPMENT AND TUMORIGENESIS
Tashakori, M. (2015) · Digital Commons-TMC (Texas Medical Center)
Functional Analysis of Tumor Suppressor Genes in Mice
Jones, S. N., & Donehower, L. A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-329-1:283
Self-citationStochastic modelling of tumorigenesis in p53 deficient transgenic mice
Mao, J. (1997) · Enlighten: Theses (The University of Glasgow)
Investigation of PIN1 as a Genetic Modifier in Li-Fraumeni Syndrome
Villani, A. (2015) · TSpace (University of Toronto)
Husaini, R. (2014) · Bradford Scholars (University of Bradford)
New Animal Models in Toxicology
Floyd, E. (2002) · Elsevier eBooks · doi:10.1016/b978-012330215-1/50014-4
INVESTIGATING THE MOLECULAR REGULATION OF ANGIOGENESIS IN THE HEART
Dukinfield, M. (2019)
Gruber, L., Schneider, B., Nothnagel, C., & Beer‐Hammer, S. (2022) · European Journal of Immunology · doi:10.1002/eji.202250017
p53 Models for Mammary Carcinogenesis
Deppert, W., & Tolstonog, G. V. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8_7
Neural- and Endocrine-Cell-Specific Immortalization Using Transgenic Approaches
Kumar, T. R. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-102-2_20
Manipulating the p53 Gene in the Mouse: Organismal Functions of a Prototype Tumor Suppressor
Donehower, L. A., Bocangel, D., Dumble, M. L., & Lozano, G. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_8
Self-citationYun, W. B., Kim, J. E., Lee, M. L., Choi, J. Y., Park, J. J., Song, B. R., Kang, B. C., Nam, K. T., Lee, H.-W., & Hwang, D. Y. (2021) · Figshare · doi:10.6084/m9.figshare.17089606
Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53 R270H/+ Mice
Panzeri, I., Madaj, Z., Fagnocchi, L., Apostle, S., Tompkins, M., Gallik, K., Ma, E. H., Hostetter, G. H., Jones, R. G., & Pospisilik, J. A. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0280
CREATION OF A MOUSE WITH A HUMANIZED fpgs GENE COMPATIBLE WITH NORMAL DEVELOPMENT
Xie, L. (2008) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/hzh1-dc84
Metadata
- Authors
- Donehower, L. A., Harvey, M., Vogel, H., McArthur, M. J., Montgomery, C. A., Park, S. H., Thompson, T., Ford, R. J., & Bradley, A.
- Affiliations
- Baylor College of Medicine (US)
- Harvard University (US)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Molecular Carcinogenesis
- Publisher
- Wiley
- Published
- 1995-09
- Volume
- 14
- Issue
- 1
- Pages
- 16-22
- ISSN
- 0899-1987 (ISSN-L)
- 1098-2744
- OpenAlex
- W2093294267
- Cited by
- 252
- References
- 20
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 11 · 2020: 7 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 7 · 2015: 8 · 2014: 6 · 2013: 9 · 2012: 12
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Carcinogenesis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-50588, CA-16672, R01CA050588, CA54897, R01CA054897, P30CA016672)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Keywords
- p53 deficiency, carcinogenesis, genetic background, 129/Sv mice, malignant teratoma, thymic lymphoma, B-cell lymphoma, Li-Fraumeni syndrome, cancer susceptibility, spontaneous tumors
- MeSH terms
- Alleles, Animals, Crosses, Genetic, Disease Models, Animal, Genetic Engineering, Heterozygote, Humans, Lymphoma, Mice, Inbred C57BL, Mice, Mutant Strains, Neoplasms, Experimental, Genes, p53, Tumor Suppressor Protein p53, Li-Fraumeni Syndrome, Genetic Predisposition to Disease, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.